ES3004083T3 - Mass spectrometry assay method for detection and quantitation of kidney function metabolites - Google Patents

Mass spectrometry assay method for detection and quantitation of kidney function metabolites Download PDF

Info

Publication number
ES3004083T3
ES3004083T3 ES17885159T ES17885159T ES3004083T3 ES 3004083 T3 ES3004083 T3 ES 3004083T3 ES 17885159 T ES17885159 T ES 17885159T ES 17885159 T ES17885159 T ES 17885159T ES 3004083 T3 ES3004083 T3 ES 3004083T3
Authority
ES
Spain
Prior art keywords
analytes
ion
analyte
tryptophan
mobile phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17885159T
Other languages
English (en)
Spanish (es)
Inventor
Lisa Ford
Tiffany Freed
Deirdre Hauser
Kelli Goodman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metabolon Inc
Original Assignee
Metabolon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolon Inc filed Critical Metabolon Inc
Application granted granted Critical
Publication of ES3004083T3 publication Critical patent/ES3004083T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/62—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving urea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0009—Calibration of the apparatus
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0027—Methods for using particle spectrometers
    • H01J49/0031—Step by step routines describing the use of the apparatus
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/004—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn
    • H01J49/0045—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn characterised by the fragmentation or other specific reaction
    • H01J49/005—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn characterised by the fragmentation or other specific reaction by collision with gas, e.g. by introducing gas or by accelerating ions with an electric field
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/02—Details
    • H01J49/10—Ion sources; Ion guns
    • H01J49/14—Ion sources; Ion guns using particle bombardment, e.g. ionisation chambers
    • H01J49/145—Ion sources; Ion guns using particle bombardment, e.g. ionisation chambers using chemical ionisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7057—(Intracellular) signaling and trafficking pathways
    • G01N2800/7066—Metabolic pathways
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Plasma & Fusion (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
ES17885159T 2016-12-19 2017-12-14 Mass spectrometry assay method for detection and quantitation of kidney function metabolites Active ES3004083T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662435967P 2016-12-19 2016-12-19
US201762526043P 2017-06-28 2017-06-28
US201762558014P 2017-09-13 2017-09-13
PCT/US2017/066364 WO2018118630A1 (en) 2016-12-19 2017-12-14 Mass spectrometry assay method for detection and quantitation of kidney function metabolites

Publications (1)

Publication Number Publication Date
ES3004083T3 true ES3004083T3 (en) 2025-03-11

Family

ID=62627087

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17885159T Active ES3004083T3 (en) 2016-12-19 2017-12-14 Mass spectrometry assay method for detection and quantitation of kidney function metabolites

Country Status (8)

Country Link
US (1) US11619636B2 (https=)
EP (1) EP3555615B9 (https=)
JP (1) JP7393206B2 (https=)
CN (1) CN110088615B (https=)
AU (1) AU2017382744B2 (https=)
CA (1) CA3045022C (https=)
ES (1) ES3004083T3 (https=)
WO (1) WO2018118630A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3555615B9 (en) 2016-12-19 2025-03-19 Metabolon, Inc. Mass spectrometry assay method for detection and quantitation of kidney function metabolites
CN112689755A (zh) * 2018-09-11 2021-04-20 梅塔博隆股份有限公司 用于检测和定量微生物区系相关代谢物的质谱测定法
CN113508293B (zh) * 2019-04-24 2024-05-07 株式会社岛津制作所 成像质量分析装置
WO2020242744A1 (en) * 2019-05-31 2020-12-03 Metabolon, Inc. Mass spectrometry assay methods for detection of metabolites
CN112946150B (zh) * 2019-11-26 2024-06-18 深圳华大临床检验中心 一种快速检测人体尿液中高香草酸、香草扁桃酸、5-羟基吲哚乙酸及肌酐的方法及试剂盒
CN111007173A (zh) * 2019-12-20 2020-04-14 辉源生物科技（上海）有限公司 吲哚胺2，3-二氧化酶抑制剂的筛选方法
CN114026427B (zh) * 2020-05-19 2023-11-17 深圳市中医院 诊断肾病的标志物以及诊断方法
CN115917323A (zh) * 2020-05-19 2023-04-04 赛诺菲 使用干血样验证药物水平的方法
CN114518413B (zh) * 2020-11-18 2024-12-31 江苏天士力帝益药业有限公司 一种卡托普利原料药中脯氨酸的含量测定方法
CN114216984B (zh) * 2021-12-16 2023-10-13 川北医学院附属医院 一种骨质疏松症负离子诊断标志物及其检测方法
CN114414700A (zh) * 2022-01-27 2022-04-29 重庆迪纳利医药科技有限责任公司 一种同时测定生物样品中多种内源性糖醇含量的方法和系统
WO2025244008A1 (ja) * 2024-05-23 2025-11-27 株式会社島津製作所 測定方法、プログラム、および高速液体クロマトグラフタンデム質量分析装置

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2248147A1 (en) 2008-01-31 2010-11-10 DH Technologies Development Pte. Ltd. High-throughput screening of metabolic disorders using a laser desorption ion source coupled to a mass analyzer
JP5624709B2 (ja) * 2008-03-13 2014-11-12 大日本住友製薬株式会社 内因性代謝物の分析方法
WO2010126146A1 (ja) 2009-04-30 2010-11-04 Tanaka Noriaki 腎疾患重篤度を判定する方法又は装置若しくはその作動方法
CN107064330B (zh) 2010-12-28 2022-02-25 探索诊断投资公司 通过质谱法定量胰岛素
JP2015505965A (ja) * 2011-12-09 2015-02-26 メタボロン，インコーポレイテッド 腎癌のバイオマーカーおよびそれを用いる方法
CN102680599A (zh) 2012-05-11 2012-09-19 上海特敏生物医药科技有限公司 尿肌氨酸及肌酐测定试剂盒
ES2987582T3 (es) * 2013-01-31 2024-11-15 Metabolon Inc Biomarcadores relacionados con la progresión de la resistencia a la Insulina y métodos que lo utilizan
JP6595984B2 (ja) 2013-05-14 2019-10-23 メタボロン，インコーポレイテッド 腎機能に関連付けられるバイオマーカーおよびそれを使用する方法
CN105143872B (zh) * 2013-06-07 2019-03-01 皮尔斯生物科技有限公司 通过质谱分析用复用内标物对蛋白质和蛋白质修饰的绝对定量
WO2015014903A2 (en) 2013-07-31 2015-02-05 Pharnext Diagnostic tools for alzheimer's disease
WO2016025429A1 (en) * 2014-08-15 2016-02-18 The Johns Hopkins University Precise estimation of glomerular filtration rate from multiple biomarkers
CN105738626B (zh) * 2014-12-12 2017-07-14 中国科学院大连化学物理研究所 一种新的血清代谢物的组合及其作为肝癌诊断标志物的用途
US20160282371A1 (en) * 2015-03-28 2016-09-29 Quantalytical Labs Inc. Solid Phase Extraction, Derivatization with Crown Ethers, and Mass Spectrometry, Methods, Reagents and Kits
BR112017025097B1 (pt) * 2015-05-27 2021-05-11 Quest Diagnostics Investments Llc método para quantificação espectrométrica de massa de analitos extraídos de um dispositivo de microamostragem
CN104897821A (zh) 2015-06-03 2015-09-09 福建中烟工业有限责任公司 提取样品中肌醇的方法、试剂盒及其用途
EP3555615B9 (en) 2016-12-19 2025-03-19 Metabolon, Inc. Mass spectrometry assay method for detection and quantitation of kidney function metabolites

Also Published As

Publication number Publication date
JP7393206B2 (ja) 2023-12-06
WO2018118630A1 (en) 2018-06-28
AU2017382744A1 (en) 2019-06-13
EP3555615A1 (en) 2019-10-23
EP3555615B9 (en) 2025-03-19
JP2020502544A (ja) 2020-01-23
EP3555615A4 (en) 2020-11-04
CN110088615A (zh) 2019-08-02
CN110088615B (zh) 2023-08-22
AU2017382744B2 (en) 2023-02-09
CA3045022A1 (en) 2018-06-28
US20190346455A1 (en) 2019-11-14
US11619636B2 (en) 2023-04-04
CA3045022C (en) 2024-01-16
EP3555615B1 (en) 2024-10-30

Similar Documents

Publication Publication Date Title
ES3004083T3 (en) Mass spectrometry assay method for detection and quantitation of kidney function metabolites
Nalbantoglu Metabolomics: basic principles and strategies
US11181530B2 (en) Mass spectrometry method for detection and quantitation of metabolites
Ren et al. Advances in mass spectrometry-based metabolomics for investigation of metabolites
Junot et al. High resolution mass spectrometry based techniques at the crossroads of metabolic pathways
Wong et al. An overview of label-free quantitation methods in proteomics by mass spectrometry
BR112017018821B1 (pt) Método para determinação da quantidade de insulina e peptídeo c
Ozohanics et al. GlycoMiner: a new software tool to elucidate glycopeptide composition
Lind et al. The use of mass spectrometry for analysing metabolite biomarkers in epidemiology: methodological and statistical considerations for application to large numbers of biological samples
US20100084545A1 (en) Methods for Detecting Vitamin C by Mass Spectrometry
AU2019248549A1 (en) Mass spectrometry assay method for detection and quantitation of liver function metabolites
Mirnaghi et al. Challenges of analyzing different classes of metabolites by a single analytical method
Ishige et al. Improved sensitivity of serum/plasma 1α, 25-dihydroxyvitamin D quantification by DAPTAD derivatization
Yao et al. A sensitive method for the determination of the gender difference of neuroactive metabolites in tryptophan and dopamine pathways in mouse serum and brain by UHPLC-MS/MS
Chekmeneva et al. Development of nanoelectrospray high resolution isotope dilution mass spectrometry for targeted quantitative analysis of urinary metabolites: application to population profiling and clinical studies
CN106370741A (zh) 一种基于亲水作用色谱飞行时间质谱的喉癌血清差异代谢物的测定筛选方法
Siwy et al. Metabolomic and proteomic techniques for establishing biomarkers and improving our understanding of pathophysiology in diabetic nephropathy
HK40014572B (en) Mass spectrometry assay method for detection and quantitation of kidney function metabolites
HK40014572A (en) Mass spectrometry assay method for detection and quantitation of kidney function metabolites
Sommer et al. Standardized targeted metabolomics using the BIOCRATES MxP quant 500 Kit on the ACQUITY UPLC I-class PLUS and Xevo TQ-XS mass spectrometer
Zheng et al. A rapid and sensitive LC–MS–MS method for determination of hepcidin-25 in human serum, and measurement of its diurnal rhythm for healthy subjects
EP4689669A1 (en) Methods for quantitation of adiponectin by mass spectrometry
PAPAGIANNOPOULOU Metabolomics’ study for the predisposing factors of cardiotoxicity occurrence, in pediatric patients with neoplasia submitted to different antineoplastic protocols.
CN111239283A (zh) 焦谷氨酸作为判断代谢组学血液样本质量的质检指示物的应用
BR112019020473B1 (pt) Métodos para medir a resistência à insulina em pacientes diabéticos ou pré-diabéticos